Data in this press release contain forward-looking statements that involve risks and uncertainties. The Company’s actual results could differ materially from anticipated in these statements due to certain factors , which are described in the Company’s prospectus.
The pre-diabetic and diabetic patients suffer from overlapping disorders (hypertension, dyslipidemia, insulin resistance, inflammation of developing type of developing type II diabetes and the associated micro-and macro – vascular disease: Heart attack. Stroke, retinopathy, kidney disease, diabetic foot or arteritis?The award each year on a company whose competition strategy is revealed significant gains in market share during the investigation period. – MEDISON did strong growth the the world biggest and most modern markets, obtained by aggressive strategies and customer-oriented management, said Arun Karthik W, principal analyst by Frost & Sullivan. In particular, it is demonstrated great achievement in high-end 3D ultrasonic system, he added.